EdgarScope

Free, fast access to the SEC EDGAR database. Search 10-K, 10-Q and 8-K filings for every registered U.S. public company.

Browse

Filing Search
All Tickers A–Z
About EdgarScope

Related Research

A filing tells you what happened. For what it means, our companion site breaks down U.S. earnings reports, dividend screens and beginner-friendly algorithmic trading strategies.

FNReportU.S. Equity Insights · written in Korean

© 2026 EdgarScope. Filing data is sourced from the U.S. Securities and Exchange Commission EDGAR system. EdgarScope is an independent service and is not affiliated with, endorsed by, or sponsored by the SEC. Nothing on this site constitutes investment advice.

ATOSSA THERAPEUTICS, INC. (ATOS)

Ticker: ATOSCIK: 0001488039

34

Filings Found (Last 1 Year)

8-K2026. 9. 29.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

8-K2026. 9. 18.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

8-K2026. 8. 7.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

10-Q2026. 6. 30.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Quarterly report10-Q

424B52026. 6. 12.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Prospectus424B5

8-K2026. 6. 10.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

42026. 5. 12.

Steinhart Richard I (CIK 0001293789)

Insider trading report4

42026. 5. 12.

Chen Shu-Chih (CIK 0001552127)

Insider trading report4

42026. 5. 12.

Remmel H. Lawrence (CIK 0001551817)

Insider trading report4

42026. 5. 12.

Finn Jonathan (CIK 0001981595)

Insider trading report4

42026. 5. 12.

Galli Stephen J (CIK 0001551951)

Insider trading report4

42026. 5. 12.

Cigler Tessa (CIK 0002015142)

Insider trading report4

8-K2026. 5. 8.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

10-Q2026. 3. 31.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Quarterly report10-Q

8-K2026. 5. 7.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

8-K2026. 4. 13.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

42026. 3. 27.

QUAY STEVEN C (CIK 0001008227)

Insider trading report4

42026. 3. 26.

Daniel Mark James (CIK 0002092593)

Insider trading report4

10-K2025. 12. 31.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Annual report10-K

8-K2026. 3. 25.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

8-K2026. 2. 19.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

424B52026. 2. 20.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Prospectus424B5

8-K2026. 2. 17.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

8-K2026. 2. 11.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

4/A2026. 1. 20.

QUAY STEVEN C (CIK 0001008227)

4/A4/A

8-K2026. 1. 20.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

42026. 1. 20.

QUAY STEVEN C (CIK 0001008227)

Insider trading report4

8-K2026. 1. 9.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

8-K2026. 1. 6.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

8-K2025. 12. 4.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

10-Q2025. 9. 30.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Quarterly report10-Q

8-K2025. 11. 12.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

42025. 10. 14.

Daniel Mark James (CIK 0002092593)

Insider trading report4

8-K2025. 10. 14.

ATOSSA THERAPEUTICS, INC. (ATOS) (CIK 0001488039)

Current report8-K

PreviousPage 1 of 2Next

ATOS SEC Filings | SEC Document SEARCH